BIODEFENSE AND EMERGING INFECTIOUS DISEASES RESEARCH OPPORTUNITIES - CORRECTION TO PA-03-080 RELEASE DATE: May 27, 2003 NOTICE: NOT-AI-03-040 National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/default.htm) PURPOSE The research plan for R21 grant applications is limited to 15 pages, not 10 pages as stated in PA-03-080. Corrected supplemental instructions for R21 applications follow. CORRECTED SUPPLEMENTAL INSTRUCTIONS FOR R21 APPLICATIONS: To apply, please follow NIH guidelines for submission of an R21 application (http://grants.nih.gov/grants/guide/pa-files/PA-03-107.html) as listed below: 1) The description (abstract) must include a brief explanation of the proposed activity, and how it is consistent with the exploratory/development nature of the R21 mechanism as described in this notice. 2) Although preliminary data are neither expected nor required for an R21 application, they may be included. 3) Sections a-d of the Research Plan may not exceed 15 pages, including tables and figures. 4) Appendix materials should be limited, as is consistent with the exploratory nature of the R21 mechanism, and should not be used to circumvent the page limit for the research plan. Copies of appendix material will only be provided to the primary reviewers of the application and will not be reproduced for wider distribution. The following materials may be included in the appendix: o Up to five publications, including manuscripts (submitted or accepted for publication), abstracts, patents, or other printed materials directly relevant to the project. These may be stapled as sets. o Surveys, questionnaires, data collection instruments, and clinical protocols. These may be stapled as sets. o Original glossy photographs or color images of gels, micrographs, etc., provided that a photocopy (may be reduced in size) is also included within the 15-page limit of items a-d of the research plan. Include five collated sets of all appendix material, in the same package with the application, following all copies of the application. Identify each item with the name of the principal investigator. SENDING AN R21 APPLICATION TO THE NIH: Submit a signed, typewritten original of the application, including the checklist, and five signed photocopies and all appendices in one package to: Center for Scientific Review National Institutes of Health 6701 Rockledge Drive, Room 1040, MSC 7710 Bethesda, MD 20892-7710 Bethesda, MD 20817 (for express/courier service) INQUIRIES We encourage your inquiries concerning this notice and welcome the opportunity to answer questions from potential applicants. Direct inquiries to: Sam Perdue, Ph.D. Program Officer, Rickettsial and Related Diseases National Institute of Allergy and Infectious Disease Room 4115; 6610 Rockledge Dr. Bethesda, MD 20817 Telephone: 301/402-5083 Fax: 301/402-2508 Email: sp189u@nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||
NIH... Turning Discovery Into Health® |